Fractionation
Showing 51 - 75 of 613
DIPG Trial in Mumbai (Bevacizumab Injection, Ultra-low-dose RT)
Recruiting
- DIPG
- Bevacizumab Injection
- Ultra-low-dose RT
-
Mumbai, Maharashtra, IndiaTata Memorial Hospital
Apr 28, 2022
Bladder Cancer Trial in Seoul (hypo-IMRT)
Recruiting
- Bladder Cancer
- hypo-IMRT
-
Seoul, Korea, Republic ofSamsung Medical Center
Jul 6, 2022
Prostate Cancer, Radiotherapy Side Effect, Hypofractionation Trial in Quebec (grade and compare reported side effects between
Recruiting
- Prostate Cancer
- +5 more
- grade and compare reported side effects between groups
-
Quebec, CanadaCHUdeQuebec
Mar 14, 2023
Tumor Metastases, Metastases, Tumor Trial in United States (EXTERNAL BEAM RADIATION)
Not yet recruiting
- Neoplasm Metastases
- Metastases, Neoplasm
- EXTERNAL BEAM RADIATION
-
Hamilton, New Jersey
- +4 more
Nov 16, 2022
Esophageal Squamous Cell Carcinoma, Chemo Effect, Side Effect of Drug Trial in Nanjing (Consolidation chemo (4 courses),
Recruiting
- Esophageal Squamous Cell Carcinoma
- +2 more
- Consolidation chemotherapy (4 courses)
- Concurrent chemotherapy (2 courses)
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital of Nanjing Medical University
Mar 16, 2023
Metastatic Renal Cell Carcinoma, Brain Metastases Trial in United States (drug, device, radiation)
Recruiting
- Metastatic Renal Cell Carcinoma
- Brain Metastases
- Cabozantinib
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Nov 10, 2023
Stage III Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8 Trial (External Beam Radiation Therapy, Stereotactic Body
Not yet recruiting
- Stage III Prostate Cancer AJCC v8
- Stage IVA Prostate Cancer AJCC v8
- External Beam Radiation Therapy
- Stereotactic Body Radiation Therapy
- (no location specified)
Jul 20, 2023
Diffuse Midline Glioma, H3 K27M-Mutant, Diffuse Intrinsic Pontine Glioma, Diffuse Glioma Trial (Re-irradiation)
Not yet recruiting
- Diffuse Midline Glioma, H3 K27M-Mutant
- +5 more
- Re-irradiation
- (no location specified)
Oct 16, 2023
Hepatocellular Carcinoma, Narrow Margin, Adjuvant Stereotactic Body Radiotherapy Trial in Hangzhou (stereotactic body radiation
Not yet recruiting
- Hepatocellular Carcinoma
- +3 more
- stereotactic body radiation therapy
- regular follow-up
-
Hangzhou, Zhejiang, Chinathe second affiliated hospital of Zhejiang University
Nov 3, 2022
Breast Cancer Trial (Proton Therapy)
Not yet recruiting
- Breast Cancer
- Proton Therapy
- (no location specified)
May 3, 2023
Cancer of Head and Neck, Mucositis Oral, Pharyngeal Mucositis Trial in Lake Success (Ketamine Topical)
Not yet recruiting
- Cancer of Head and Neck
- +2 more
- Ketamine Topical
-
Lake Success, New YorkCenter for Advanced Medicine
Nov 1, 2022
Identification of Breath Biomarkers in Esophageal Cancer
Recruiting
- Esophageal Squamous Cell Carcinoma
- Breathing test
-
Guangzhou, Guangdong, ChinaMian Xi
Oct 27, 2022
Head Neck Cancer Trial in Canada (biological, drug, radiation)
Completed
- Head and Neck Cancer
- panitumumab
- +4 more
-
Edmonton, Alberta, Canada
- +18 more
Apr 2, 2020
Hematologic Diseases, Hematologic Malignancy, Acute Lymphoblastic Leukemia Trial in Miami (device, procedure, drug)
Withdrawn
- Hematologic Diseases
- +5 more
- CliniMACS
- +7 more
-
Miami, FloridaMiami Cancer Institute at Baptist Health, Inc.
Sep 26, 2022
HF-SRT vs. HS-WBRT in Treating Brain Oligometastases
Not yet recruiting
- Brain Oligometastases
- Hypofractionated Stereotactic Radiotherapy (HF-SRT)
- Hippocampus-Sparing Whole-Brain Radiotherapy (HS-WBRT) plus memantine
-
Taoyuan, TaiwanChang Gung Memorial Hospital
Mar 28, 2023
Squamous Cell Carcinoma of the Head and Neck Trial in Worldwide (Xevinapant (Debio 1143), Cisplatin, Intensity Modulation
Recruiting
- Squamous Cell Carcinoma of the Head and Neck
- Xevinapant (Debio 1143)
- +3 more
-
Gilbert, Arizona
- +280 more
Aug 22, 2022
Head and Neck Tumors Trial in Worldwide (biological, drug, radiation)
Active, not recruiting
- Head and Neck Neoplasms
- Pembrolizumab
- +4 more
-
Los Angeles, California
- +150 more
Dec 7, 2022
(LTFU) of Patients Treated With Genome-edited Autologous
Not yet recruiting
- Sickle Cell Disease
- OTQ923
- (no location specified)
Nov 24, 2023
Brain Metastases, Adult Trial in Rozzano (Silibinin)
Recruiting
- Brain Metastases, Adult
- Silibinin
-
Rozzano, Milano, ItalyIRCCS Humanitas Research Hospital
Mar 20, 2023
Head Neck Cancer Trial in United States (drug, radiation, procedure)
Skull Base Meningioma Trial in Heidelberg (Carbon Ion Radiotherapy, Proton Therapy, Hypofractionated Photon Radiotherapy)
Withdrawn
- Skull Base Meningioma
- Carbon Ion Radiotherapy
- +3 more
-
Heidelberg, GermanyUniversity Hospital of Heidelberg, Radiation Oncology
Sep 28, 2021
Esophagus Cancer Trial in Guangzhou (Cadonilimab, Paclitaxel and cisplatin, intensity-modulated radiotherapy)
Not yet recruiting
- Esophagus Cancer
- Cadonilimab
- +2 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University
Nov 20, 2023
Head Neck Cancer, Hypoxia, FMISO Trial in Brno, Olomouc, Ostrava (Dose escalation)
Active, not recruiting
- Head and Neck Cancer
- +3 more
- Dose escalation
-
Brno, Czechia
- +2 more
May 5, 2022
Prostate Cancer Trial in Baltimore (hypofractionation)
Active, not recruiting
- Prostate Cancer
- hypofractionation
-
Baltimore, MarylandThe Johns Hopkins University School of Medicne
Mar 18, 2022